21 octubre 2014
A new study shows that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Eg8GYmVXOvk/141021111458.htm
